XML 29 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Financial Instruments (Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations) (Details) (Derivatives Designated As Hedging Instruments [Member], Foreign Currency Forward Contracts [Member], USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized in OCI-Effective Portion $ 164 [1] $ 542 [1] $ 2,257 [1]
Gain or (Loss) Reclassified from OCI into Income-Effective Portion 194 [1] 809 [1] 2,004 [1]
Amount of Gain or (Loss) Recognized in Income and Excluded from Effectiveness Testing (158) (310) (261)
Net Revenue [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Reclassified from OCI into Income-Effective Portion 262 [1] 967 [1] 2,755 [1]
Other Income (Expense), Net [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Recognized in Income and Excluded from Effectiveness Testing (158) (310) (261)
Cost Of Revenue [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Reclassified from OCI into Income-Effective Portion (1) [1] (4) [1] (27) [1]
Operating Expenses [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Reclassified from OCI into Income-Effective Portion $ (67) [1] $ (154) [1] $ (724) [1]
[1] Refer to Note 10, Stockholders' Equity, which summarizes the cumulative other comprehensive income activity related to derivatives.